Join the Oncology Voice Network. Join for Free
TEXT: Mapping Customer Journeys in a Digital World
Key Opinion Leaders Digital Communication Medical Science Liaison Social Media Engagement Compassionate Leadership

TEXT: Mapping Customer Journeys in a Digital World


Share This Article


Summary

In this episode, Tom Caravela is joined by Mitchell D’Rozario to explore the challenges and strategies in engaging with Key Opinion Leaders (KOLs). They discuss the importance of understanding digital communication preferences and establishing value through effective timing and methods. The conversation delves into leveraging publication history and digital tools to enhance MSL access and engagement, while balancing virtual and in-person interactions. They highlight the role of compassionate leadership, navigating social media, and adapting strategies in difficult times. Mitchell shares insights on overcoming obstacles, learning from failures, and provides tips for aspiring MSLs.

Mitchell D’Rozario, Medical Science Liaison at Genentech discusses digital tools and techniques for MSLs to Map Customer Journeys: pain points and opportunities.

Mitch shares…

👉 How to go about developing a TEXT relationship with your Key Opinion Leaders

👉 What key questions you should be asking

👉 How and why the use of social media is so important

👉 Unique ways to engage with KOLs and gain better access

👉 Advice on performance and meeting goals

Click for Source
Key Opinion Leaders, Digital Communication, Medical Science Liaison, Social Media Engagement, Compassionate Leadership

Related Topics

Meet Our Innovation Partners

Loading partners...

You May Also Like

Podcast
Social Media Listening Evolved
Partner Avatar MSL Talk: Tom Caravela, Conor McGladrigan, Kevin Peterson

Social Media Listening Evolved

Podcast
Over-Negotiation-How to Botch a Job Offer
Partner Avatar MSL Talk: Tom Caravela

Over-Negotiation-How to Botch a Job Offer

Article
Median Survival or Mean Survival: Which Measure Is the Most Appropriate for Patients, Physicians, and Policymakers?
OVN Avatar Omer Ben‐Aharon, Racheli Magnezi, Moshe Leshno, and Daniel A. Goldstein

Median Survival or Mean Survival: Which Measure Is the Most Appropriate for Patients, Physicians, and Policymakers?

Press Release
Announcing the Launch of Voices of Oncology: A Landmark Collaboration with Forbes
OVN Avatar OVN Staff

Announcing the Launch of Voices of Oncology: A Landmark Collaboration with Forbes

Press Release
Introducing OncologyVoiceNetwork.com
OVN Avatar OVN Staff

Introducing OncologyVoiceNetwork.com

Article
Updated estimates of eligibility for and response to genome-targeted oncology drugs among US cancer patients, 2006-2020
OVN Avatar A. Haslam, M.S. Kim, V. Prasad

Updated estimates of eligibility for and response to genome-targeted oncology drugs among US cancer patients, 2006-2020

Explore OVN